ADGRL3 and urinary bladder carcinoma: In some of these studies, ChIP assay confirmed AR binding to the promoter regions of, for example, ADAR2 [70], ADGRL3 [67], and CD44 [71] genes in bladder cancer cells, indicating the direct regulation of their expression by AR.